Welcome to the website of the OncoProteomics Laboratory, a proteomics center with a focus on innovative clinical proteomics and (inter)national collaboration.
MISSION
The mission of the OPL is to develop/implement and apply innovative proteomics and data analysis strategies to improve (early) diagnostics and treatment of disease, most notably cancer.
ORIGINS and EMBEDDING
The OncoProteomics Laboratory (OPL) was founded in 2006 with a start-up grant of the VUmc-Cancer Center Amsterdam and is embedded in the department of Medical Oncology. The OPL performs biomarker research in many collaborative projects within CCA/V-ICI, VUmc, as well as at the national (CTMM projects) and international level (EU projects) (see diagram below). The focus is on oncogenesis and cancer research in the context of patient selection for targeted therapy and therapy resistance.
Current main areas of OPL research activities and collaborations